메뉴 건너뛰기




Volumn 7, Issue 1, 2014, Pages

Experiences in anti-tuberculosis treatment in patients with multiple previous treatments and its impact on drug resistant tuberculosis epidemics

Author keywords

China; Drug resistance; Second line anti tuberculosis drugs; Treatment history; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

EID: 84927973249     PISSN: None     EISSN: 16549880     Source Type: Journal    
DOI: 10.3402/gha.v7.24593     Document Type: Article
Times cited : (10)

References (30)
  • 2
    • 84861874346 scopus 로고    scopus 로고
    • National survey of drug-resistant tuberculosis in China
    • Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 2012; 366: 2161-70.
    • (2012) N Engl J Med , vol.366 , pp. 2161-2170
    • Zhao, Y.1    Xu, S.2    Wang, L.3    Chin, D.P.4    Wang, S.5    Jiang, G.6
  • 3
    • 33750864910 scopus 로고    scopus 로고
    • Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control
    • Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec 2006; 81: 430-2.
    • (2006) Wkly Epidemiol Rec , vol.81 , pp. 430-432
  • 4
    • 33645119729 scopus 로고    scopus 로고
    • Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004
    • Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006; 55: 301-5.
    • (2006) MMWR Morb Mortal Wkly Rep , vol.55 , pp. 301-305
  • 5
    • 77953655525 scopus 로고    scopus 로고
    • Multi-drug resistant tuberculosis burden and risk factors: an update
    • Marahatta SB. Multi-drug resistant tuberculosis burden and risk factors: an update. Kathmandu Univ Med J (KUMJ) 2010; 8: 116-25.
    • (2010) Kathmandu Univ Med J (KUMJ) , vol.8 , pp. 116-125
    • Marahatta, S.B.1
  • 6
    • 77955240567 scopus 로고    scopus 로고
    • Extensively drug-resistant tuberculosis: epidemiology and management challenges
    • Dheda K, Warren RM, Zumla A, Grobusch MP. Extensively drug-resistant tuberculosis: epidemiology and management challenges. Infect Dis Clin North Am 2010; 24: 705-25.
    • (2010) Infect Dis Clin North Am , vol.24 , pp. 705-725
    • Dheda, K.1    Warren, R.M.2    Zumla, A.3    Grobusch, M.P.4
  • 8
    • 77957037450 scopus 로고    scopus 로고
    • 2010 global report on surveillance and response. Geneva, Switzerland: World Health Organization
    • World Health Organization. (2010). Multidrug and extensively drug-resistant tuberculosis (M/XDR-TB). 2010 global report on surveillance and response. Geneva, Switzerland: World Health Organization.
    • (2010) Multidrug and extensively drug-resistant tuberculosis (M/XDR-TB)
  • 10
    • 66949174024 scopus 로고    scopus 로고
    • Radiological findings of extensively drug-resistant pulmonary tuberculosis in non-AIDS adults: comparisons with findings of multidrug-resistant and drug-sensitive tuberculosis
    • Cha J, Lee HY, Lee KS, Koh WJ, Kwon OJ, Yi CA, et al. Radiological findings of extensively drug-resistant pulmonary tuberculosis in non-AIDS adults: comparisons with findings of multidrug-resistant and drug-sensitive tuberculosis. Korean J Radiol 2009; 10: 207-16.
    • (2009) Korean J Radiol , vol.10 , pp. 207-216
    • Cha, J.1    Lee, H.Y.2    Lee, K.S.3    Koh, W.J.4    Kwon, O.J.5    Yi, C.A.6
  • 11
    • 84860469092 scopus 로고    scopus 로고
    • Social behaviour risk factors for drug resistant tuberculosis in mainland China: a meta-analysis
    • Zhao P, Li XJ, Zhang SF, Wang XS, Liu CY. Social behaviour risk factors for drug resistant tuberculosis in mainland China: a meta-analysis. J Int Med Res 2012; 40: 436-45.
    • (2012) J Int Med Res , vol.40 , pp. 436-445
    • Zhao, P.1    Li, X.J.2    Zhang, S.F.3    Wang, X.S.4    Liu, C.Y.5
  • 12
    • 60849094830 scopus 로고    scopus 로고
    • Comparative analysis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis-epidemiology and predictive factors
    • Vilarica AS, Gomes C, Pina J. Comparative analysis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis-epidemiology and predictive factors. Rev Port Pneumol 2008; 14: 829-42.
    • (2008) Rev Port Pneumol , vol.14 , pp. 829-842
    • Vilarica, A.S.1    Gomes, C.2    Pina, J.3
  • 13
    • 70349817126 scopus 로고    scopus 로고
    • Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
    • Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res 2009; 9: 169.
    • (2009) BMC Health Serv Res , vol.9 , pp. 169
    • Xu, W.1    Lu, W.2    Zhou, Y.3    Zhu, L.4    Shen, H.5    Wang, J.6
  • 14
    • 45349090112 scopus 로고    scopus 로고
    • DOT in rural China: experience from a case study in Shandong Province, China
    • Sun Q, Meng Q, Yip W, Yin X, Li H. DOT in rural China: experience from a case study in Shandong Province, China. Int J Tuberc Lung Dis 2008; 12: 625-30.
    • (2008) Int J Tuberc Lung Dis , vol.12 , pp. 625-630
    • Sun, Q.1    Meng, Q.2    Yip, W.3    Yin, X.4    Li, H.5
  • 15
    • 53949095828 scopus 로고    scopus 로고
    • Barriers to accessing TB diagnosis for rural-to-urban migrants with chronic cough in Chongqing, China: a mixed methods study
    • Long Q, Li Y, Wang Y, Yue Y, Tang C, Tang S, et al. Barriers to accessing TB diagnosis for rural-to-urban migrants with chronic cough in Chongqing, China: a mixed methods study. BMC Health Serv Res 2008; 8: 202.
    • (2008) BMC Health Serv Res , vol.8 , pp. 202
    • Long, Q.1    Li, Y.2    Wang, Y.3    Yue, Y.4    Tang, C.5    Tang, S.6
  • 16
    • 43949110267 scopus 로고    scopus 로고
    • Decentralising tuberculosis services from county tuberculosis dispensaries to township hospitals in China: an intervention study
    • Wei X, Liang X, Liu F, Walley JD, Dong B. Decentralising tuberculosis services from county tuberculosis dispensaries to township hospitals in China: an intervention study. Int J Tuberc Lung Dis 2008; 12: 538-47.
    • (2008) Int J Tuberc Lung Dis , vol.12 , pp. 538-547
    • Wei, X.1    Liang, X.2    Liu, F.3    Walley, J.D.4    Dong, B.5
  • 17
    • 83455186284 scopus 로고    scopus 로고
    • Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China
    • Yao S, Huang WH, van den Hof S, Yang SM, Wang XL, Chen W, et al. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China. BMC Health Serv Res 2011; 11: 341.
    • (2011) BMC Health Serv Res , vol.11 , pp. 341
    • Yao, S.1    Huang, W.H.2    van den Hof, S.3    Yang, S.M.4    Wang, X.L.5    Chen, W.6
  • 18
    • 37549042773 scopus 로고    scopus 로고
    • Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study
    • Hu D, Liu X, Chen J, Wang Y, Wang T, Zeng W, et al. Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study. Health Policy Plan 2008; 23: 43-55.
    • (2008) Health Policy Plan , vol.23 , pp. 43-55
    • Hu, D.1    Liu, X.2    Chen, J.3    Wang, Y.4    Wang, T.5    Zeng, W.6
  • 19
    • 79955781618 scopus 로고    scopus 로고
    • For tuberculosis elimination, directly observed therapy, short course (DOTS) is essential but not sufficient
    • Fanning A. For tuberculosis elimination, directly observed therapy, short course (DOTS) is essential but not sufficient. Int J Circumpolar Health 2011; 70: 106-8.
    • (2011) Int J Circumpolar Health , vol.70 , pp. 106-108
    • Fanning, A.1
  • 20
    • 33644995903 scopus 로고    scopus 로고
    • Progress of DOTS in global tuberculosis control
    • Sharma SK, Liu JJ. Progress of DOTS in global tuberculosis control. Lancet 2006; 367: 951-2.
    • (2006) Lancet , vol.367 , pp. 951-952
    • Sharma, S.K.1    Liu, J.J.2
  • 21
    • 47549102958 scopus 로고    scopus 로고
    • Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis
    • Lew W, Pai M, Oxlade O, Martin D, Menzies D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med 2008; 149: 123-34.
    • (2008) Ann Intern Med , vol.149 , pp. 123-134
    • Lew, W.1    Pai, M.2    Oxlade, O.3    Martin, D.4    Menzies, D.5
  • 24
    • 84876122461 scopus 로고    scopus 로고
    • Selected culture and drug-susceptibility testing methods for drugresistant Mycobacterium tuberculosis screening in resourceconstrained settings
    • Ausina Ruiz V, Fernandez-Rivas G, Vilaplana Messeguer C. Selected culture and drug-susceptibility testing methods for drugresistant Mycobacterium tuberculosis screening in resourceconstrained settings. Expert Rev Mol Diagn 2013; 13: 247-9.
    • (2013) Expert Rev Mol Diagn , vol.13 , pp. 247-249
    • Ausina Ruiz, V.1    Fernandez-Rivas, G.2    Vilaplana Messeguer, C.3
  • 25
    • 84875602728 scopus 로고    scopus 로고
    • Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test
    • Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 2013; 13: 349-61.
    • (2013) Lancet Infect Dis , vol.13 , pp. 349-361
    • Lawn, S.D.1    Mwaba, P.2    Bates, M.3    Piatek, A.4    Alexander, H.5    Marais, B.J.6
  • 26
    • 80053067126 scopus 로고    scopus 로고
    • WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
    • Falzon D, Jaramillo E, Schunemann HJ, Arentz M, Bauer M, Bayona J, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-28.
    • (2011) Eur Respir J , vol.38 , pp. 516-528
    • Falzon, D.1    Jaramillo, E.2    Schunemann, H.J.3    Arentz, M.4    Bauer, M.5    Bayona, J.6
  • 27
    • 77953629601 scopus 로고    scopus 로고
    • Availability of second-line drugs and anti-tuberculosis drug susceptibility testing in China: a situational analysis
    • He GX, van den Hof S, Borgdorff MW, van der Werf MJ, Cheng SM, Hu YL, et al. Availability of second-line drugs and anti-tuberculosis drug susceptibility testing in China: a situational analysis. Int J Tuberc Lung Dis 2010; 14: 884-9.
    • (2010) Int J Tuberc Lung Dis , vol.14 , pp. 884-889
    • He, G.X.1    van den Hof, S.2    Borgdorff, M.W.3    van der Werf, M.J.4    Cheng, S.M.5    Hu, Y.L.6
  • 28
    • 84930274566 scopus 로고    scopus 로고
    • China-Japan cooperation project on second-line tuberculosis drug resistance survey in Henan Province
    • Zhang G, Du C, Kurasawa T, Ikeda X, Wang W, Shi R, et al. China-Japan cooperation project on second-line tuberculosis drug resistance survey in Henan Province. J Med Forum 2005; 26: 14-16.
    • (2005) J Med Forum , vol.26 , pp. 14-16
    • Zhang, G.1    Du, C.2    Kurasawa, T.3    Ikeda, X.4    Wang, W.5    Shi, R.6
  • 29
    • 2942574537 scopus 로고    scopus 로고
    • Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, after the implementation of DOTS-plus, 1995-2002
    • Kam KM, Yip CW. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, after the implementation of DOTS-plus, 1995-2002. Int J Tuberc Lung Dis 2004; 8: 760-6.
    • (2004) Int J Tuberc Lung Dis , vol.8 , pp. 760-766
    • Kam, K.M.1    Yip, C.W.2
  • 30
    • 84880278957 scopus 로고    scopus 로고
    • Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China
    • Hu Y, Hoffner S, Wu L, Zhao Q, JiangW, Xu B. Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China. Antimicrob Agents Chemother 2013; 57: 3857-63.
    • (2013) Antimicrob Agents Chemother , vol.57 , pp. 3857-3863
    • Hu, Y.1    Hoffner, S.2    Wu, L.3    Zhao, Q.4    Jiang, W.5    Xu, B.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.